Hariri Robert J — SEC Form 4 filings
SEC reporting owner CIK 1398815. 15 Form 4 filings on record with FilingPulse; latest filed 2026-06-08.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-02-21 to 2026-06-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings — 48,000 shares, $405,048 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 25,000 shares @ $9.71 ($242,738) in Cryoport, Inc., filed 2025-09-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cryoport, Inc. (CYRX) | Director | 9 | — | 7 legs · 48,000 sh · $405,048 | 8 |
| Celularity Inc (CELU) | Chief Executive Officer, Director | 5 | — | — | 11 |
| BIOVIE INC. (BIVI) | Director | 1 | — | — | 2 |
Form 4 filings — Hariri Robert J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-08 | 4 | Cryoport, Inc. (CYRX) | Grant/award (A): 10,350 @ $0 · Grant/award (A): 16,077 (derivative) @ $0 | EDGAR |
| 2026-04-15 | 4 | Celularity Inc (CELU) | Option exercise (M): 3,281 @ $0 · Tax withholding (F): 1,182 @ $1.28 · Option exercise (M): 3,281 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | Cryoport, Inc. (CYRX) | Option exercise (M): 50,000 @ $2.66 · Sale (S): 25,000 @ $9.71 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2025-08-29 | 4 | Cryoport, Inc. (CYRX) | Sale (S): 5,000 @ $8.60 | EDGAR |
| 2025-06-10 | 4 | Cryoport, Inc. (CYRX) | Grant/award (A): 23,214 @ $0 · Grant/award (A): 41,098 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4/A | Celularity Inc (CELU) | Option exercise (M): 3,281 @ $0 · Tax withholding (F): 1,154 @ $1.64 · Option exercise (M): 3,281 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Cryoport, Inc. (CYRX) | Sale (S): 12,500 @ $6.10 | EDGAR |
| 2025-04-15 | 4 | Celularity Inc (CELU) | Option exercise (M): 3,281 @ $0 · Tax withholding (F): 1,154 @ $1.64 · Option exercise (M): 3,281 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | BIOVIE INC. (BIVI) | Grant/award (A): 49,800 (derivative) @ $0 · Grant/award (A): 21,815 (derivative) @ $0 | EDGAR |
| 2024-12-02 | 4 | Cryoport, Inc. (CYRX) | Sale (S): 2,500 @ $6.48 | EDGAR |
| 2024-08-26 | 4 | Cryoport, Inc. (CYRX) | Sale (S): 1,000 @ $9.46 | EDGAR |
| 2024-08-20 | 4 | Cryoport, Inc. (CYRX) | Sale (S): 1,000 @ $8.40 · Sale (S): 1,000 @ $9 | EDGAR |
| 2024-05-21 | 4 | Cryoport, Inc. (CYRX) | Grant/award (A): 12,845 @ $0 · Grant/award (A): 23,830 (derivative) @ $0 | EDGAR |
| 2024-04-16 | 4 | Celularity Inc (CELU) | Tax withholding (F): 1,154 @ $4.11 | EDGAR |
| 2024-02-21 | 4 | Celularity Inc (CELU) | Grant/award (A): 2,937,788 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1398815 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →